Seeing Is Believing
AMGN is currently covered by 22 analysts with an average price target of $295.79. This is a potential upside of $30.15 (11.35%) from yesterday's end of day stock price of $265.64.
Amgen's activity chart (see below) currently has 431 price targets and 380 ratings on display. The stock rating distribution of AMGN is 38.89% HOLD, 50% BUY and 11.11% SELL.
Analysts average stock forecasts to be materialized ratio is 92.35% with an average time for these price targets to be met of 546.35 days.
Highest price target for AMGN is $350, Lowest price target is $200, average price target is $295.79.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 08-Feb-2024.
Amgen is a biotechnology company that specializes inĀ developing, manufacturing, and delivering human therapeutics.
The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.
Currently out of the existing stock ratings of AMGN, 35 are a HOLD (38.89%), 45 are a BUY (50%), 10 are a SELL (11.11%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
350
$80.8 (30.01%)
258
2 months 11 days ago
1/2 (50%)
$57.44 (19.63%)
325
Buy
329
$59.8 (22.21%)
300
2 months 12 days ago
6/8 (75%)
$35.42 (12.06%)
68
Buy
350
$80.8 (30.01%)
310
2 months 18 days ago
29/30 (96.67%)
$27.96 (8.68%)
508
Hold
314
$44.8 (16.64%)
272
2 months 21 days ago
8/8 (100%)
$2.98 (0.96%)
96
Buy
345
$75.8 (28.16%)
310
3 months 16 days ago
22/23 (95.65%)
$46.64 (15.63%)
610
What is AMGN (Amgen) average time for price targets to be met?
Which analyst has the current highest performing score on AMGN (Amgen) with a proven track record?
Which analyst has the most public recommendations on AMGN (Amgen)?
Which analyst is the currently most bullish on AMGN (Amgen)?
Which analyst is the currently most reserved on AMGN (Amgen)?